Bibliography
- BISHOP AC, UBERSAX JA, PETSCH DT et al.: A chemical switch for inhibitor-sensitive alleles of any protein kinase. Nature (2000) 407(6802):395-401.
- BISHOP AC, BUZKO O, SHOKAT KM: Magic bullets for protein kinases. Trends Cell Biol. (2001) 11(4):167-172.
- BISHOP AC, SHOKAT KM: Acquisition of inhibitor-sensitive protein kinases through protein design. Pharmacol. Ther. (1999) 82(2-3):337-346.
- KNIGHT ZA, SHOKAT KM: Features of selective kinase inhibitors. Chem. Biol. (2005) 12(6):621-637.
- ALAIMO PJ, KNIGHT ZA, SHOKAT KM: Targeting the gatekeeper residue in phosphoinositide 3-kinases. Bioorg. Med. Chem. (2005) 13(8):2825-2836.
- COHEN MS, ZHANG C, SHOKAT KM, TAUNTON J: Structural bioinformatics-based design of selective, irreversible kinase inhibitors. Science (2005) 308(5726):1318-1321.
- ZHANG C, KENSKI DM, PAULSON JL et al.: A second-site suppressor strategy for chemical genetic analysis of diverse protein kinases. Nat. Methods (2005) 2(6):435-441.
- PAPA FR, ZHANG C, SHOKAT K, WALTER P: Bypassing a kinase activity with an ATP-competitive drug. Science (2003) 302(5650): 1533-1537.
- ABELIOVICH H, ZHANG C, DUNN WA Jr, SHOKAT KM, KLIONSKY DJ: Chemical genetic analysis of Apg1 reveals a non-kinase role in the induction of autophagy. Mol. Biol. Cell (2003) 14(2):477-490.
- WEISS EL, BISHOP AC, SHOKAT KM, DRUBIN DG: Chemical genetic analysis of the budding-yeast p21-activated kinase Cla4p. Nat. Cell Biol. (2000) 2(10):677-685.
- SREENIVASAN A, BISHOP AC, SHOKAT KM, KELLOGG DR: Specific inhibition of Elm1 kinase activity reveals functions required for early G1 events. Mol. Cell Biol. (2003) 23(17):6327-6337.
- CARROLL AS, BISHOP AC, DERISI JL, SHOKAT KM, O’SHEA EK: Chemical inhibition of the Pho85 cyclin-dependent kinase reveals a role in the environmental stress response. Proc. Natl. Acad. Sci. USA (2001) 98(22):12578-12583.
- VENTURA JJ, HUBNER A, ZHANG C, FLAVELL RA, SHOKAT KM, DAVIS RJ: Chemical genetic analysis of the time course of signal transduction by JNK. Mol. Cell (2006) 21(5):701-710.
- EBLEN ST, KUMAR NV, SHAH K et al.: Identification of novel ERK2 substrates through use of an engineered kinase and ATP analogs. J. Biol. Chem. (2003) 278(17):14926-14935.
- HABELHAH H, SHAH K, HUANG L, BURLINGAME AL, SHOKAT KM, RONAI Z: Identification of new JNK substrate using ATP pocket mutant JNK and a corresponding ATP analogue. J. Biol. Chem. (2001) 276(21):18090-18095.
- FAN QW, SPECHT KM, ZHANG C, GOLDENBERG DD, SHOKAT KM, WEISS WA: Combinatorial efficacy achieved through two-point blockade within a signaling pathway-a chemical genetic approach. Cancer Res. (2003) 63(24):8930-8938.
- FAN QW, ZHANG C, SHOKAT KM, WEISS WA: Chemical genetic blockade of transformation reveals dependence on aberrant oncogenic signaling. Curr. Biol. (2002) 12(16):1386-1394.
- WONG S, WITTE ON: The BCR-ABL story: bench to bedside and back. Ann. Rev. Immunol. (2004) 22:247-306.
- WONG S, MCLAUGHLIN J, CHENG D, ZHANG C, SHOKAT KM, WITTE ON: Sole BCR-ABL inhibition is insufficient to eliminate all myeloproliferative disorder cell populations. Proc. Natl. Acad. Sci. USA (2004) 101(50):17456-17461.
- KUNG C, SHOKAT KM: Small-molecule kinase-inhibitor target assessment. Chembiochem (2005) 6(3):523-526.